184 related articles for article (PubMed ID: 35877008)
1. Altered expression of a disintegrin and metalloproteinase 10 in peripheral blood mononuclear cells in type 2 diabetes mellitus patients with the acute coronary syndrome: a pilot study.
Ragavi R; Adole PS; Vinod KV; Pillai AA
Endocrine; 2022 Sep; 77(3):461-468. PubMed ID: 35877008
[TBL] [Abstract][Full Text] [Related]
2. Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes.
Lee AC; Lam JK; Shiu SW; Wong Y; Betteridge DJ; Tan KC
PLoS One; 2015; 10(9):e0137330. PubMed ID: 26325204
[TBL] [Abstract][Full Text] [Related]
3. The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.
Paradela-Dobarro B; Agra RM; Álvarez L; Varela-Román A; García-Acuña JM; González-Juanatey JR; Álvarez E; García-Seara FJ
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1050-1060. PubMed ID: 31371263
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
Tam XH; Shiu SW; Leng L; Bucala R; Betteridge DJ; Tan KC
Clin Sci (Lond); 2011 Jan; 120(2):81-9. PubMed ID: 20726839
[TBL] [Abstract][Full Text] [Related]
5. Association between carbonyl stress markers and the risk of acute coronary syndrome in patients with type 2 diabetes mellitus-A pilot study.
Bora S; Adole PS; Motupalli N; Pandit VR; Vinod KV
Diabetes Metab Syndr; 2020; 14(6):1751-1755. PubMed ID: 32932181
[TBL] [Abstract][Full Text] [Related]
6. Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes.
Phimphilai M; Pothacharoen P; Kongtawelert P
Front Endocrinol (Lausanne); 2021; 12():726182. PubMed ID: 34512554
[TBL] [Abstract][Full Text] [Related]
7. Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children.
Saito R; Araki S; Yamamoto Y; Kusuhara K
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):63-69. PubMed ID: 27941172
[TBL] [Abstract][Full Text] [Related]
8. Metabolic dysfunction in Emirati subjects in Abu Dhabi: Relationship to levels of soluble RAGEs.
Abdulle A; Inman CK; Saleh A; Noshi M; Galani D; Abdelwareth L; Alsafar H; Elfatih A; Al Shamsi H; Ali R; Li H; Ramasamy R; Schmidt AM; Benbarka MM; Hassan MH
J Clin Transl Endocrinol; 2019 Jun; 16():100192. PubMed ID: 31080742
[TBL] [Abstract][Full Text] [Related]
9. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
[TBL] [Abstract][Full Text] [Related]
10. ADAM10 modulates calcitriol-regulated RAGE in cardiomyocytes.
Lee TW; Kao YH; Lee TI; Chen YJ
Eur J Clin Invest; 2017 Sep; 47(9):675-683. PubMed ID: 28722189
[TBL] [Abstract][Full Text] [Related]
11. Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality.
Prasad K
Int J Angiol; 2014 Mar; 23(1):11-6. PubMed ID: 24627612
[TBL] [Abstract][Full Text] [Related]
12. Serum advanced glycation end-products and receptors as prognostic biomarkers in diabetics undergoing coronary artery stent implantation.
Shen Y; Pu LJ; Lu L; Zhang Q; Zhang RY; Shen WF
Can J Cardiol; 2012; 28(6):737-43. PubMed ID: 23073352
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study.
Sabbatinelli J; Castiglione S; Macrì F; Giuliani A; Ramini D; Vinci MC; Tortato E; Bonfigli AR; Olivieri F; Raucci A
Cardiovasc Diabetol; 2022 Jun; 21(1):95. PubMed ID: 35668468
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitus.
Farhan SS; Hussain SA
Diabetes Metab Syndr; 2019; 13(4):2457-2461. PubMed ID: 31405660
[TBL] [Abstract][Full Text] [Related]
15. Circulating soluble RAGE isoforms are attenuated in obese, impaired-glucose-tolerant individuals and are associated with the development of type 2 diabetes.
Miranda ER; Somal VS; Mey JT; Blackburn BK; Wang E; Farabi S; Karstoft K; Fealy CE; Kashyap S; Kirwan JP; Quinn L; Solomon TPJ; Haus JM
Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E631-E640. PubMed ID: 28811295
[TBL] [Abstract][Full Text] [Related]
16. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
[TBL] [Abstract][Full Text] [Related]
17. Receptor for advanced glycation end products polymorphisms in coronary artery ectasia.
Aslan EI; Ozkara G; Kilicarslan O; Ser OS; Bostan C; Yildiz A; Diren Borekcioglu A; Ozturk O; Kucukhuseyin O; Yilmaz Aydogan H
Gene; 2024 Jul; 916():148450. PubMed ID: 38588932
[TBL] [Abstract][Full Text] [Related]
18. Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals.
Scavello F; Tedesco CC; Castiglione S; Maciag A; Sangalli E; Veglia F; Spinetti G; Puca AA; Raucci A
Biomark Med; 2021 Aug; 15(11):785-796. PubMed ID: 34236256
[TBL] [Abstract][Full Text] [Related]
19. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
[TBL] [Abstract][Full Text] [Related]
20. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
Melin EO; Dereke J; Hillman M
Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]